• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症干细胞发育、功能及疾病中的表观转录组学

Epitranscriptomics in the development, functions, and disorders of cancer stem cells.

作者信息

Hao Linlin, Zhang Jian, Liu Zhongshan, Lin Xia, Guo Jie

机构信息

Department of Tumor Radiotherapy, The Second Hospital of Jilin University, Changchun, China.

School of Life Sciences, Department of Biology, Southern University of Science and Technology, Shenzhen, China.

出版信息

Front Oncol. 2023 Mar 17;13:1145766. doi: 10.3389/fonc.2023.1145766. eCollection 2023.

DOI:10.3389/fonc.2023.1145766
PMID:37007137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10063963/
Abstract

Biomolecular modifications play an important role in the development of life, and previous studies have investigated the role of DNA and proteins. In the last decade, with the development of sequencing technology, the veil of epitranscriptomics has been gradually lifted. Transcriptomics focuses on RNA modifications that affect gene expression at the transcriptional level. With further research, scientists have found that changes in RNA modification proteins are closely linked to cancer tumorigenesis, progression, metastasis, and drug resistance. Cancer stem cells (CSCs) are considered powerful drivers of tumorigenesis and key factors for therapeutic resistance. In this article, we focus on describing RNA modifications associated with CSCs and summarize the associated research progress. The aim of this review is to identify new directions for cancer diagnosis and targeted therapy.

摘要

生物分子修饰在生命发展过程中发挥着重要作用,先前的研究已经探讨了DNA和蛋白质的作用。在过去十年中,随着测序技术的发展,表观转录组学的面纱逐渐被揭开。转录组学关注的是在转录水平上影响基因表达的RNA修饰。随着进一步研究,科学家们发现RNA修饰蛋白的变化与癌症的发生、发展、转移和耐药性密切相关。癌症干细胞(CSCs)被认为是肿瘤发生的强大驱动因素和治疗耐药的关键因素。在本文中,我们重点描述与癌症干细胞相关的RNA修饰,并总结相关研究进展。本综述的目的是确定癌症诊断和靶向治疗的新方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1830/10063963/ef13874637fc/fonc-13-1145766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1830/10063963/681bf66a676d/fonc-13-1145766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1830/10063963/010787cbd107/fonc-13-1145766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1830/10063963/ef13874637fc/fonc-13-1145766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1830/10063963/681bf66a676d/fonc-13-1145766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1830/10063963/010787cbd107/fonc-13-1145766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1830/10063963/ef13874637fc/fonc-13-1145766-g003.jpg

相似文献

1
Epitranscriptomics in the development, functions, and disorders of cancer stem cells.癌症干细胞发育、功能及疾病中的表观转录组学
Front Oncol. 2023 Mar 17;13:1145766. doi: 10.3389/fonc.2023.1145766. eCollection 2023.
2
Cancer epitranscriptomics in a nutshell.癌症表观转录组学概述。
Curr Opin Genet Dev. 2022 Aug;75:101924. doi: 10.1016/j.gde.2022.101924. Epub 2022 Jun 6.
3
Regulation of Formation, Stemness and Therapeutic Resistance of Cancer Stem Cells.癌症干细胞的形成、干性及治疗抗性的调控
Front Cell Dev Biol. 2021 Apr 7;9:641498. doi: 10.3389/fcell.2021.641498. eCollection 2021.
4
Epitranscriptomics in liver disease: Basic concepts and therapeutic potential.肝疾病中的表观转录组学:基础概念与治疗潜能。
J Hepatol. 2020 Sep;73(3):664-679. doi: 10.1016/j.jhep.2020.04.009. Epub 2020 Apr 21.
5
Towards a druggable epitranscriptome: Compounds that target RNA modifications in cancer.迈向可药物干预的表观转录组:靶向癌症中RNA修饰的化合物。
Br J Pharmacol. 2022 Jun;179(12):2868-2889. doi: 10.1111/bph.15604. Epub 2021 Jul 27.
6
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications.癌症药物耐药性中的转录组学和蛋白质组学:治疗意义。
Signal Transduct Target Ther. 2020 Sep 8;5(1):193. doi: 10.1038/s41392-020-00300-w.
7
[RNA methylation: regulations and mechanisms].[RNA甲基化:调控与机制]
Yi Chuan. 2018 Nov 20;40(11):964-976. doi: 10.16288/j.yczz.18-175.
8
Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells.天然产物对癌症干细胞自噬调节作用的治疗潜力的分子见解
Front Cell Dev Biol. 2020 Apr 24;8:283. doi: 10.3389/fcell.2020.00283. eCollection 2020.
9
Exploring epitranscriptomics for crop improvement and environmental stress tolerance.探索表观转录组学在作物改良和环境胁迫耐受方面的应用。
Plant Physiol Biochem. 2022 Jul 15;183:56-71. doi: 10.1016/j.plaphy.2022.04.031. Epub 2022 May 7.
10
RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.RNA 修饰与表观遗传学在调控肺癌及肺部疾病中的作用。
Int J Mol Sci. 2021 Sep 30;22(19):10592. doi: 10.3390/ijms221910592.

引用本文的文献

1
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy.哺乳动物癌症干细胞耐药性的综合综述:对癌症治疗的启示
Cancer Cell Int. 2024 Dec 18;24(1):406. doi: 10.1186/s12935-024-03558-0.
2
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson's Disease.环境表观转录组学和 RNA 修饰在帕金森病中的新兴作用。
J Parkinsons Dis. 2024;14(4):643-656. doi: 10.3233/JPD-230457.

本文引用的文献

1
DirectRMDB: a database of post-transcriptional RNA modifications unveiled from direct RNA sequencing technology.DirectRMDB:一个从直接 RNA 测序技术中揭示的转录后 RNA 修饰数据库。
Nucleic Acids Res. 2023 Jan 6;51(D1):D106-D116. doi: 10.1093/nar/gkac1061.
2
m6A-TSHub: Unveiling the Context-specific mA Methylation and mA-affecting Mutations in 23 Human Tissues.m6A-TSHub:揭示 23 个人类组织中特定上下文的 mA 甲基化和 mA 影响突变。
Genomics Proteomics Bioinformatics. 2023 Aug;21(4):678-694. doi: 10.1016/j.gpb.2022.09.001. Epub 2022 Sep 9.
3
RMDisease V2.0: an updated database of genetic variants that affect RNA modifications with disease and trait implication.
RMDisease V2.0:一个更新的数据库,包含影响 RNA 修饰的遗传变异,与疾病和表型特征有关。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1388-D1396. doi: 10.1093/nar/gkac750.
4
Targeted therapy for breast cancer: An overview of drug classes and outcomes.乳腺癌的靶向治疗:药物类别与治疗结果概述
Biochem Pharmacol. 2022 Oct;204:115209. doi: 10.1016/j.bcp.2022.115209. Epub 2022 Aug 14.
5
Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches.空间表转录组学揭示了癌症干细胞微龛中特定的 A 到 I 编辑组。
Nat Commun. 2022 May 9;13(1):2540. doi: 10.1038/s41467-022-30299-3.
6
RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness Regulating p53.RNA去甲基化酶ALKBH5通过调节EMT和干性调节p53来阻止肺癌进展。
Front Oncol. 2022 Apr 22;12:858694. doi: 10.3389/fonc.2022.858694. eCollection 2022.
7
Role of main RNA modifications in cancer: N-methyladenosine, 5-methylcytosine, and pseudouridine.主要 RNA 修饰在癌症中的作用:N6-甲基腺苷、5-甲基胞嘧啶和假尿嘧啶。
Signal Transduct Target Ther. 2022 Apr 28;7(1):142. doi: 10.1038/s41392-022-01003-0.
8
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.中国和美国 2022 年癌症统计数据:概况、趋势和决定因素。
Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108.
9
ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance.ADAR1 介导的 RNA 编辑将神经节苷脂代谢与神经胶质瘤干细胞维持联系起来。
J Clin Invest. 2022 Mar 15;132(6). doi: 10.1172/JCI143397.
10
Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis.靶向PUS7可抑制tRNA假尿苷化和胶质母细胞瘤的肿瘤发生。
Nat Cancer. 2021 Sep;2(9):932-949. doi: 10.1038/s43018-021-00238-0. Epub 2021 Aug 16.